Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
tazarotene
Medication labelWhy this: Advisory · dailymed-prescription
TAZORAC® (tazarotene) Gel 0.05% and 0.1% are indicated for the topical treatment of patients with stable plaque psoriasis of up to 20% body surface area involvement. TAZORAC® (tazarotene) Gel 0.1% is also indicated for the topical treatment of patients with facial acne vulgaris of mild to moderate severity. The efficacy of TAZORAC® Gel in the treatment of acne previously treated with other retinoids or resistant to oral antibiotics has not been established.
- generic_name
- tazarotene
- product_names
- Tazarotene
- ndc
- 54868-4456, 0023-0042, 54868-4456-0, 54868-4456-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en